Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchSpecialized Academic Departments and Institutes
Research, Drug Development & Manufacturing

University of Texas Southwestern Medical Center

4 Trials

UT Southwestern Medical Center is a leading academic medical center in Dallas, Texas, combining research, education, and patient care. It houses the Peter O'Donnell Jr. Brain Institute and participates in clinical trials investigating ketamine and psychedelic-adjacent compounds for treatment-resistant depression and other neuropsychiatric conditions.

Academic Research

0 papers

Published Papers

0

Trial Involvement

4

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
hospital
Website
Visit

Sponsored Trials

4
RecruitingII

Ketamine for Methamphetamine Use Disorder (KMD)

Start Date
Compounds
Ketamine, Placebo
RecruitingI

Ketamine in Severe Traumatic Brain Injury

Start Date
Compounds
Ketamine
CompletedIII

Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents

Start Date
Compounds
Ketamine
TerminatedI

The Effects of Low Dose Ketamine on Cardiovascular Function

Start Date
Compounds
Ketamine, Placebo